Teen To Graduate, Despite Fatal Disease PDF Print E-mail
Wednesday, 09 June 2010 09:07
A rare and life threatening medical disorder has kept a Portsmouth teen out of school and unable to walk for months, but Wednesday night he will walk the stage at his graduation. Wednesday night, families will be filing into the N-Telos pavilion in Portsmouth to celebrate the graduation of Churchland High School's class of 2010, and all they've accomplished over the past four years.

But what one student accomplished over the past four weeks might just leave them in awe. "I feel good that I'm still alive," said Jawuan Trotter, who was diagnosed with Scleroderma. While his Churchland classmates have been busy planning new lives, in January Jawuan Trotter was planning for his death.

"I was thinking of my own will in my head; it was a hard time," he said. It was almost unimaginable for the confident teen, who was voted homecoming prince. "We started to notice his hands became very thick and leather like," said Jawuan's mother Desiree Trotter.

His doctor diagnosed him with Scleroderma.

"We had never heard of it," his mother said. "We didn't know what it was, didn't know how to spell it, but she asked us not to look online, because Scleroderma is often deadly and rarely diagnosed in children.

"I think this may be the first patient we've had on our inpatient rehab unit," said Dr. Jean Shelton. She says Scleroderma is an auto-immune disorder; Jawuan's immune system is essentially attacking his own body. "In his case, [the disease] attacks the brain, the spinal chord, as well as the soft tissues, the hands and the arms and throughout the body," Shelton said.

It got so bad, Jawuan could not stand for more than five seconds.

"When I couldn't go to school anymore it was depressing, very depressing," said Jawuan. He started working with therapists at Children's Hospital of the King's Daughters in April. But come Wednesday, it'ill be worth it. "He's graduating with a 3.38 advanced honors diploma," said Desiree Trotter. "That's awesome."

Source: Wavy.com
 
More articles :

» Placebo-controlled Study of Methotrexate in Juvenile Localised Scleroderma

According to the results of this placebo-controlled study, is an effective treatment for juvenile localised scleroderma (JLS). The authors note that JLS is a chronic progressive fibrotic process of the skin causing permanent disability and...

» The Mississauga Support Group To Host Annual Fundraiser

The Mississauga Support Group of the Scleroderma Society of Ontario will host its annual fundraising dinner and dance gala on April 2 at the Oasis Convention Centre. Funds raised will go to the Scleroderma Society of Ontario to fund research,...

» Dermatomyositis

Dermatomyositis is one of a group of muscle diseases known as the inflammatory myopathies, which are characterized by chronic muscle inflammation accompanied by muscle weakness. Dermatomyositis’ cardinal symptom is a skin rash that precedes or...

» Systemic Sclerosis Patients Treated With Oral Treprostinil Diethanolamine

Patients with effectively absorbed oral treprostinil diethanolamine, which produced a temporal association with improved cutaneous perfusion and temperature, according to study results. In a dual-center, open-label, phase 1 study, researchers...

» Scleroderma in Children: Emerging Management Issues

Saumya PandaDepartment of Dermatology, KPC Medical College, Kolkata, IndiaDate of Web Publication: 21-Jul-2010Abstract         Scleroderma is a set of rare connective tissue diseases of unknown etiology. It is...

» Scientists Identify New Genetic Region Associated with Scleroderma

New research supported, in part, by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) has identified a new genetic link to systemic sclerosis (also known as systemic scleroderma) and confirmed three previously...